Table 1.
Baseline Characteristics of Study Population
| Factors | Study Population |
|---|---|
| Baselines characteristics : | |
| Sex (% Male) | 60 (75.95%) |
| Age (years) | 62.55±11.55 |
| Presence of cirrhosis | 74 (93.67%) |
| - Child-Pugh A | 51 (64.56%) |
| - Child-Pugh B | 23 (29.11%) |
| Viral hepatitis infection | 55 (69.62%) |
| Etiology | |
| - HBV infection | 37 (46.84%) |
| - HCV infection | 19 (24.05%) |
| - Alcohol | 8 (10.13%) |
| - Alcohol + HBV/HCV infection | 5 (6.33%) |
| - Hemochromatosis | 1 (1.27%) |
| Preoperative MELD score | 10.49±4.18 |
| Largest mass diameter (cm.) | 4.14± 3.05 |
| Presence of portal hypertension* | 45 (56.96%) |
| Mass number | |
| - 1 | 50 (63.29%) |
| - 2 | 15 (18.99%) |
| - 3 | 12 (15.19%) |
| - > 3 | 2 (2.53%) |
| Intrahepatic vascular involvement | 9 (11.39%) |
| Staging : | |
| BCLC Staging | |
| - BCLC 0 | 10 (12.66%) |
| - BCLC A | 55 (69.62%) |
| - BCLC B | 13 (16.45%) |
| - BCLC C | 1 (1.27%) |
| HKLC Staging | |
| - HKLC I | 41 (51.90%) |
| - HKLC IIa | 19 (24.05%) |
| - HKLC IIb | 14 (17.72%) |
| - HKLC IIIa | 4 (5.06%) |
| - HKLC IIIb | 1 (1.27%) |
| Treatment : | |
| Radiofrequency ablation | 45 (56.96%) |
| Resection | 34 (43.04%) |
*
Portal hypertension is defined as presence of esophageal varices or splenomegaly with platelet count ≤ 100,000 cell